0000875320-24-000144.txt : 20240516 0000875320-24-000144.hdr.sgml : 20240516 20240516161202 ACCESSION NUMBER: 0000875320-24-000144 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240514 FILED AS OF DATE: 20240516 DATE AS OF CHANGE: 20240516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Atkinson Edward Morrow III CENTRAL INDEX KEY: 0001914164 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 24955675 MAIL ADDRESS: STREET 1: C/O 89BIO, INC. STREET 2: 142 SANSOME STREET, SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 wk-form4_1715890307.xml FORM 4 X0508 4 2024-05-14 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001914164 Atkinson Edward Morrow III C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Chief Technical Ops. Off. 0 Common Stock 2024-05-14 4 A 0 14112 0 A 30084 D Represents earned performance shares with respect to a performance stock unit award granted on 05/19/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 05/14/2024 and the shares will vest on 06/10/2024. /s/ Christiana Stevenson, Attorney-in-Fact 2024-05-16